- Q1 2024 Pharming Group NV Earnings Call TranscriptMay 08, 2024€1.05Earnings
- Q4 2023 Pharming Group NV Earnings Call TranscriptMar 14, 2024€1.05Earnings
- Q3 2023 Pharming Group NV Earnings Call TranscriptOct 26, 2023€1.14Earnings
- Q2 2023 Pharming Group NV Earnings Call TranscriptAug 03, 2023€1.08Earnings
- Pharming Group NV Annual Shareholders Meeting TranscriptMay 17, 2023
- Q1 2023 Pharming Group NV Earnings Call TranscriptMay 11, 2023€1.13Earnings
- Pharming Group NV Corporate Analyst Meeting TranscriptMar 27, 2023
- Q4 2022 Pharming Group NV Earnings Call TranscriptMar 16, 2023€1.07Earnings
- Q3 2022 Pharming Group NV Earnings Call TranscriptOct 27, 2022€1.26Earnings
- Q2 2022 Pharming Group NV Earnings Call TranscriptAug 04, 2022€0.761Earnings
- Q1 2022 Pharming Group NV Earnings Call TranscriptMay 12, 2022€0.8535Earnings
- Q4 2021 Pharming Group NV Earnings Call TranscriptMar 24, 2022€0.891Earnings
- Q4 2021 Pharming Group NV Earnings Call TranscriptMar 17, 2022€0.891Earnings
- Pharming Group NV Announces Leniolisib Results Call TranscriptFeb 03, 2022
- Q3 2021 Pharming Group NV Earnings Call TranscriptOct 28, 2021€0.7854Earnings
- Q2 2021 Pharming Group NV Earnings Call TranscriptAug 05, 2021€1Earnings
- Pharming Group NV and Orchard Therapeutics PLC Announce Collaboration to Develop and Commercialize Ex Vivo Autologous HSC Gene Therapy for Hereditary Angioedema Call TranscriptJul 01, 2021
- Pharming Group NV Annual Shareholders Meeting TranscriptMay 19, 2021
- Q1 2021 Pharming Group NV Earnings Call TranscriptMay 13, 2021€1.08Earnings
- Q4 2020 Pharming Group NV Earnings Call TranscriptMar 04, 2021€1.12Earnings
Pharming Group NV Annual Shareholders Meeting Transcript
Ladies and gentlemen, on behalf of the Chairman of the Board of Directors, I welcome you to this Annual General Meeting of Shareholders of Pharming Group N.V. We have currently technical disruption with our Chairman, Paul Sekhri, but we hope we can solve the problem in a couple of minutes. During that time, I will -- we'll start with the meeting on his behalf.
We had to decide once again to switch to the digital setup as the COVID-19 pandemic is still ongoing. As a result, you are following this meeting through a live webcast. Thank you all for your understanding. To respect the number of people that are attending, only our nonexecutives, myself, Aad de Winter; and our CEO, Sijmen de Vries; and our CFO, Jeroen Wakkerman, are in this meeting room together with our civil law notary and our Company Secretary. All other members of the Board of Directors are participating in this meeting using remote facilities. Also Mrs. Buitendijk, partner at our external auditors, Deloitte, is attending online.
At today's meeting, we will have to say goodbye to our nonexecutive, Barrie Ward, and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)